The tariff classification of Finasteride (CAS-98319-26-7), in bulk form, and Proscar® tablets, both imported from various countries
Issued February 19, 2002 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2937.29.9090, 3004.39.0050
Product description
The first product, Finasteride, is a synthetic steroid analogue that functions as an anti-androgen by inhibiting steroid Type II 5(alpha)-reductase, an intracellular enzyme that converts the androgen (hormone) testosterone into 5(alpha)-dihydrotestosterone (DHT). The second product, Proscar® tablets, is an oral medication containing Finasteride as the active ingredient. It is indicated for the treatment of benign prostatic hyperplasia (BPH) in men with an enlarged prostate.
CBP rationale
The applicable subheading for Finasteride, imported in bulk form, will be 2937.29.9090, Harmonized Tariff Schedule of the United States (HTS), which provides for “Steroidal hormones, their derivatives and structural analogues: Other: Other: Other. The applicable subheading for Proscar® tablets will be 3004.39.0050, HTS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Containing hormones or other products of heading 2937 but not containing antibiotics: Other: Other.
Full text
NY H88208 February 19, 2002 CLA-2-29:RR:NC:2:238 H88208 CATEGORY: Classification TARIFF NO.: 2937.29.9090; 3004.39.0050 Jack D. Mlawski, Esq. Galvin & Mlawski 470 Park Avenue South Suite 200 - South Tower New York, NY 10016-6819 RE: The tariff classification of Finasteride (CAS-98319-26-7), in bulk form, and Proscar® tablets, both imported from various countries Dear Mr. Mlawski: In your letter dated January 31, 2002, on behalf of your client, Merck & Co., Inc., you requested a tariff classification ruling. The first product, Finasteride, is a synthetic steroid analogue that functions as an anti-androgen by inhibiting steroid Type II 5(alpha)-reductase, an intracellular enzyme that converts the androgen (hormone) testosterone into 5(alpha)-dihydrotestosterone (DHT). The second product, Proscar® tablets, is an oral medication containing Finasteride as the active ingredient. It is indicated for the treatment of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. The applicable subheading for Finasteride, imported in bulk form, will be 2937.29.9090, Harmonized Tariff Schedule of the United States (HTS), which provides for “Steroidal hormones, their derivatives and structural analogues: Other: Other: Other.” The rate of duty will be free. The applicable subheading for Proscar® tablets will be 3004.39.0050, HTS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Containing hormones or other products of heading 2937 but not containing antibiotics: Other: Other.” The rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification and country of origin of Calcitonin Salmon Injection, USP in dosage form
The tariff classification of Leuprolide Acetate Injection in dosage form, from India
The tariff classification of Liraglutide Injection Pen in dosage form, from China
The tariff classification of ORABLOC® (Articaine Hydrochloride 4% and Epinephrine 1100,000 and 1200,000) Injection in dosage form, from Italy
The tariff classification of Estradiol Tablets in dosage form, from India
The tariff classification of Exemestane Tablets in dosage form, from China
The tariff classification of Exemestane Tablets in dosage form, from India
The tariff classification of Levothyroxine Sodium for Injection in dosage form, from India
The tariff classification of Levothyroxine Sodium Tablets in dosage form, from India
The tariff classification of Abiraterone Acetate Tablets in dosage form, from China
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →